Structural properties of a family of hydrogen-bonded co-crystals formed between gemfibrozil and hydroxy derivatives of t-butylamine, determined directly from powder X-ray diffraction data

We report the formation and structural properties of co-crystals containing gemfibrozil and hydroxy derivatives of t-butylamine H2NC(CH3)3−n(CH2OH)n, with n=0, 1, 2 and 3. In each case, a 1:1 co-crystal is formed, with transfer of a proton from the carboxylic acid group of gemfibrozil to the amino group of the t-butylamine derivative. All of the co-crystal materials prepared are polycrystalline powders, and do not contain single crystals of suitable size and/or quality for single crystal X-ray diffraction studies. Structure determination of these materials has been carried out directly from powder X-ray diffraction data, using the direct-space Genetic Algorithm technique for structure solution followed by Rietveld refinement. The structural chemistry of this series of co-crystal materials reveals well-defined structural trends within the first three members of the family (n=0, 1, 2), but significantly contrasting structural properties for the member with n=3.

[1]  E. M. Hörl,et al.  Indexing program for powder patterns especially suitable for triclinic, monoclinic and orthorhombic lattices , 1976 .

[2]  P. A. Todd,et al.  Gemfibrozil , 2012, Drugs.

[3]  V. Chernyshev,et al.  Structure determination from powder diffraction , 2001 .

[4]  H. Rietveld.  A profile refinement method for nuclear and magnetic structures , 1969 .

[5]  Roy L. Johnston,et al.  The genetic algorithm : Foundations and applications in structure solution from powder diffraction data , 1998 .

[6]  A. Markvardsen,et al.  Powder diffraction based structural studies of pharmaceuticals , 2004 .

[7]  Lynne B. McCusker,et al.  Rietveld refinement guidelines , 1999 .

[8]  E. Whitney,et al.  A Retrospective Review of the Use of Lipid‐Lowering Agents in Combination, Specifically, Gemfibrozil and Lovastatin , 1992, Pharmacotherapy.

[9]  J. W. Visser.  A fully automatic program for finding the unit cell from powder data , 1969 .

[10]  Kenneth D M Harris,et al.  How to determine structures when single crystals cannot be grown: opportunities for structure determination of molecular materials using powder diffraction data. , 2004, Chemical Society reviews.

[11]  D. Grant,et al.  Hydrogen bonding in sulfonamides. , 2001, Journal of pharmaceutical sciences.

[12]  Roy L. Johnston,et al.  Development of a multipopulation parallel genetic algorithm for structure solution from powder diffraction data , 2003, J. Comput. Chem..

[13]  M. Tremayne.  The impact of powder diffraction on the structural characterization of organic crystalline materials , 2004, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[14]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[15]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[16]  Roy L. Johnston,et al.  Developments in genetic algorithm techniques for structure solution from powder diffraction data , 2004 .

[17]  D. Louër,et al.  Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method , 1991 .

[18]  Armel Le Bail,et al.  Ab-initio structure determination of LiSbWO6 by X-ray powder diffraction , 1988 .

[19]  K. Harris,et al.  The application of a genetic algorithm for solving crystal structures from powder diffraction data , 1997 .

[20]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[21]  Jason C. Cole,et al.  DASH: a program for crystal structure determination from powder diffraction data , 2006 .

[22]  R. Young,et al.  The Rietveld method , 2006 .

[23]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[24]  Margaret C. Etter,et al.  Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .

[25]  R. Černý.  Crystal structure of non-molecular compounds from powder diffraction , 2006 .

[26]  G. S. Pawley,et al.  Unit-cell refinement from powder diffraction scans , 1981 .

[27]  K. Harris,et al.  Contemporary Advances in the Use of Powder X-Ray Diffraction for Structure Determination. , 2001, Angewandte Chemie.

[28]  Daniel Louër,et al.  Powder pattern indexing with the dichotomy method , 2004 .

[29]  O. Corrigan,et al.  Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. , 2001, International journal of pharmaceutics.

[30]  J. Bernstein,et al.  Graph-set analysis of hydrogen-bond patterns in organic crystals. , 1990, Acta crystallographica. Section B, Structural science.

[31]  Donald C. Monkhouse,et al.  Review ArticlePharmaceutical Salts , 1977 .

[32]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[33]  Kenneth D. M. Harris,et al.  CRYSTAL STRUCTURE DETERMINATION FROM POWDER DIFFRACTION DATA BY MONTE CARLO METHODS , 1994 .

[34]  Vincent Favre-Nicolin,et al.  A better FOX: using flexible modelling and maximum likelihood to improve direct-space ab initio structure determination from powder diffraction , 2004 .

[35]  Michael J. Zaworotko,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .